Home / Olanzapine / Italy
IT ATC N05AH03 · updated 2 Nov 2026
Olanzapine shortage in Italy
Is there an Olanzapine shortage in Italy?
Yes. As of 2 Nov 2026, 16 Olanzapine products are reported short in Italy, the first since 15 Jul 2022. The company estimate for the return is 16 Dec 2026 (latest 30 Jun 2027). Main reason: manufacturing problem.
Also short in Canada, Germany, France, Spain, Ireland, Austria, Belgium, Czechia, Norway, Sweden, New Zealand, Australia. All countries.
Affected products in Italy
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | OLANZAPINA ZENTIVA | ZENTIVA ITALIA S.R.L. | 15 Jul 2022 | not given | Increased demand Elevata richiesta |
| IT | OLANZAPINA ZENTIVA | ZENTIVA ITALIA S.R.L. | 30 Nov 2022 | not given | Manufacturing problem Problemi produttivi |
| IT | OLANZAPINA SUN | SUN PHARMACEUTICAL INDUSTRIES (EUROPE) B.V. | 22 May 2025 | not given | Increased demand Elevata richiesta |
| IT | OLANZAPINA MYLAN PHARMA | MYLAN S.P.A. | 15 Dec 2025 | not given | Increased demand Elevata richiesta/problemi produttivi |
| IT | OLANZAPINA VIATRIS | VIATRIS LIMITED | 1 Mar 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | OLANZAPINA ACCORD | ACCORD HEALTHCARE, S.L.U. | 1 Apr 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | OLANZAPINA AUROBINDO PHARMA ITALIA | AUROBINDO PHARMA (ITALIA) S.R.L. | 6 May 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | OLANZAPINA VIATRIS | VIATRIS LIMITED | 1 Jul 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | OLANZAPINA AUROBINDO PHARMA ITALIA | AUROBINDO PHARMA (ITALIA) S.R.L. | 9 Jul 2026 | not given | Manufacturing problem Problemi produttivi: distribuzione contingentata (carenza relativa solo al canale ospedaliero) |
| IT | OLANZAPINA MYLAN PHARMA | MYLAN S.P.A. | 1 Aug 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | OLANZAPINA SUN | SUN PHARMACEUTICAL INDUSTRIES (EUROPE) B.V. | 25 Aug 2026 | not given | Increased demand Elevata richiesta |
| IT | OLANZAPINA GLENMARK | GLENMARK ARZNEIMITTEL GMBH | 25 Sep 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | OLANZAPINA AUROBINDO | AUROBINDO PHARMA (ITALIA) S.R.L. | 7 Oct 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | ZYPREXA discontinuation | CHEPLAPHARM REGISTRATION GMBH | 22 Oct 2026 | 16 Dec 2026 | Manufacturing problem Problemi produttivi: distribuzione contingentata |
| IT | OLANZAPINA VIATRIS anticipated | VIATRIS LIMITED | 10 Nov 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | OLANZAPINA PENSA PHARMA anticipated | TOWA PHARMACEUTICAL S.P.A. | 14 Dec 2026 | 30 Jun 2027 | Manufacturing problem Problemi produttivi |
Source
AIFA (Italian Medicines Agency), licensed CC-BY 4.0. Official list. All shortages reported by marketing-authorisation holders, including medicines being withdrawn.